4-hydroxycyclophosphamide has been researched along with busulfan in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ambinder, RF; Braine, HG; Burke, PJ; Burns, WH; Colvin, OM; Kaizer, H; Santos, GW; Saral, R; Stuart, RK; Yeager, AM | 1 |
| Anasetti, C; Appelbaum, FR; Bensinger, WI; Buckner, CD; Kalhorn, TF; Lambert, K; McDonald, GB; Slattery, JT | 1 |
| Aschan, J; Barkholt, L; Hassan, M; Hassan, Z; Ringdén, O; Sjöö, F | 1 |
2 trial(s) available for 4-hydroxycyclophosphamide and busulfan
| Article | Year |
|---|---|
Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide.
Topics: Acute Disease; Adolescent; Adult; Bone Marrow; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Clinical Trials as Topic; Colony-Forming Units Assay; Combined Modality Therapy; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Platelet Count; Time Factors; Transplantation, Autologous; Whole-Body Irradiation | 1986 |
Conditioning regimen-dependent disposition of cyclophosphamide and hydroxycyclophosphamide in human marrow transplantation patients.
Topics: Adult; Bone Marrow Transplantation; Breast Neoplasms; Busulfan; Child; Chromatography, High Pressure Liquid; Cyclophosphamide; Drug Interactions; Female; Half-Life; Humans; Infusions, Intravenous; Leukemia; Male; Metabolic Clearance Rate; Middle Aged | 1996 |
1 other study(ies) available for 4-hydroxycyclophosphamide and busulfan
| Article | Year |
|---|---|
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation.
Topics: Acetylcysteine; Adult; Area Under Curve; Bilirubin; Busulfan; Child; Cyclophosphamide; Female; Glutathione; Humans; Immunosuppressive Agents; Infant; Liver; Male; Middle Aged; Stem Cell Transplantation; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome | 2003 |